Literature DB >> 1369345

Altered reactivity of immunoglobulin produced by human-human hybridoma cells transfected by pSV2-neo gene.

H Tachibana1, K Akiyama, S Shirahata, H Murakami.   

Abstract

The HB4C5 and HF10B4 cell lines are human-human hybridomas producing human IgM monoclonal antibodies (MAbs) reactive to porcine carboxypeptidase A (CPase), but not to double stranded DNA (ds DNA). We obtained G418-resistant HB4C5 and HF10B4 cells by an introduction of pSV2-neo DNA. Almost all of the G418-resistant clones produced MAbs reactive to not only the CPase but the ds DNA. The results of the inhibition ELISA suggested that the cross-reactivity of the antibodies from G418-resistant clones to CPase and ds DNA was responsible for the alteration on their antigen specificity. HB4C5 and HF10B4 cells and their G418-resistant clones produced antibodies having glycosylated lambda chain. The antibodies produced by tunicamycin-treated G418-resistant subclones of HB4C5 and HF10B4 lost the ability to bind to ds DNA, but retained the ability to bind to CPase. These results suggest that an introduction of pSV2-neo DNA into these hybridomas alters the specificities of their MAbs, and that the alteration to antigen binding specificities of their MAbs may be associated with glycosylation of the MAbs by these hybridomas.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1369345     DOI: 10.1007/bf00624760

Source DB:  PubMed          Journal:  Cytotechnology        ISSN: 0920-9069            Impact factor:   2.058


  20 in total

1.  Somatic diversification of S107 from an antiphosphocholine to an anti-DNA autoantibody is due to a single base change in its heavy chain variable region.

Authors:  A M Giusti; N C Chien; D J Zack; S U Shin; M D Scharff
Journal:  Proc Natl Acad Sci U S A       Date:  1987-05       Impact factor: 11.205

2.  Flow sorting of hybrid hybridomas using the DNA stain Hoechst 33342.

Authors:  L Karawajew; S Rudchenko; T Wlasik; I Trakht; V Rakitskaya
Journal:  J Immunol Methods       Date:  1990-05-25       Impact factor: 2.303

3.  Bispecific monoclonal antibodies from hybrid hybridomas.

Authors:  M R Suresh; A C Cuello; C Milstein
Journal:  Methods Enzymol       Date:  1986       Impact factor: 1.600

4.  A variant of the dextran-binding mouse plasmacytoma J558 with altered glycosylation of its heavy chain and decreased reactivity with polymeric dextran.

Authors:  L Matsuuchi; L A Wims; S L Morrison
Journal:  Biochemistry       Date:  1981-08-18       Impact factor: 3.162

5.  Hybrid hybridoma producing a bispecific monoclonal antibody that can focus effector T-cell activity.

Authors:  U D Staerz; M J Bevan
Journal:  Proc Natl Acad Sci U S A       Date:  1986-03       Impact factor: 11.205

6.  Attachment of carbohydrate to the variable region of myeloma immunoglobulin light chains.

Authors:  H C Sox; L Hood
Journal:  Proc Natl Acad Sci U S A       Date:  1970-07       Impact factor: 11.205

7.  Human-human hybridomas secreting antibodies specific to human lung carcinoma.

Authors:  H Murakami; S Hashizume; H Ohashi; K Shinohara; K Yasumoto; K Nomoto; H Omura
Journal:  In Vitro Cell Dev Biol       Date:  1985-10

8.  Alteration of the tumorigenic and metastatic properties of neoplastic cells is associated with the process of calcium phosphate-mediated DNA transfection.

Authors:  R S Kerbel; C Waghorne; M S Man; B Elliott; M L Breitman
Journal:  Proc Natl Acad Sci U S A       Date:  1987-03       Impact factor: 11.205

9.  Somatic mutation in a cultured mouse myeloma cell affects antigen binding.

Authors:  W D Cook; S Rudikoff; A M Giusti; M D Scharff
Journal:  Proc Natl Acad Sci U S A       Date:  1982-02       Impact factor: 11.205

10.  Glycosylation of a VH residue of a monoclonal antibody against alpha (1----6) dextran increases its affinity for antigen.

Authors:  S C Wallick; E A Kabat; S L Morrison
Journal:  J Exp Med       Date:  1988-09-01       Impact factor: 14.307

View more
  1 in total

1.  Changes of monosaccharide availability of human hybridoma lead to alteration of biological properties of human monoclonal antibody.

Authors:  H Tachibana; K Taniguchi; Y Ushio; K Teruya; K Osada; H Murakami
Journal:  Cytotechnology       Date:  1994       Impact factor: 2.058

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.